Colorado Mental Health Institute at Pueblo, 1600 W 24th St., Pueblo, CO 81003, USA.
Psychiatr Q. 2012 Sep;83(3):271-80. doi: 10.1007/s11126-011-9197-8.
The objective of this study is to understand psychiatrist's decisions to prescribe psychiatric medications. A survey questionnaire was prepared consisting of 15 factors. Each factor had a five-point Likert scale, rating the importance of each factor in making decisions to prescribe medications. Twenty-six psychiatrists at a state psychiatric hospital completed the questionnaire. The data analysis involved the frequencies of responses for each factor being compared using Chi square goodness-of-fit tests with null hypothesis that the response distribution will be centered around average score of three on the Likert scale. All the participants rated patient's symptom, severity, and diagnosis as the most important. This was followed by the patient's past experience with medications, then medication side effects, concurrent physical health problems, and medication interactions. Psychiatrist's experience with medications rated as more important than evidence from clinical trials. Finally, psychiatrists integrate evidence from research findings with personal experience, patient preferences, and clinical context in making decisions in prescribing medications for psychiatric disorders.
这项研究的目的是了解精神科医生开具精神科药物的决策。我们准备了一份调查问卷，其中包含 15 个因素。每个因素都有一个五分制的李克特量表，评估每个因素在决定开药时的重要性。一家州立精神病院的 26 名精神科医生完成了这份问卷。数据分析包括比较每个因素的反应频率，使用卡方拟合优度检验，零假设是反应分布将集中在李克特量表的平均分三上。所有参与者都将患者的症状、严重程度和诊断评为最重要的因素。其次是患者过去的用药经验，然后是药物副作用、同时存在的身体健康问题和药物相互作用。精神科医生对药物的经验被认为比临床试验的证据更重要。最后，精神科医生在为精神障碍开处方时，将研究结果的证据与个人经验、患者偏好和临床背景结合起来做出决策。
